D e s i g n
Blinded comparison of 3 Geriatric Depression Scales (GDS-4, GDS-15, and GDS-30) and the Mental Health Inventory-1 (MHI-1) scale with diagnostic criteria of research of International Classification of Diseases-10th edition (DCR-10).
S e t t i n g
A teaching hospital in the United Kingdom.
P a t i e n t s
87 patients (mean age 79 y, 60% women) who were > 60 years of age and attended the day rehabilitation facility or were admitted to the medical rehabilitation wards. Patients were excluded if they had an illness, communication problems, or a score of < 6 on the 10-item Abbreviated Mental Test (AMT).
D e s c r i p t i o n o f t e s t s a n d d i a g n o s t i c s t a n d a r d
The GDS-30, GDS-4, 10-item AMT, and 5-item MHI were administered within 48 hours after an initial interview. Data for GDS-15 and MHI-1 were extracted from GDS-30 and MHI-5. Established cut points for diagnosis of depression were used for GDS-30, GDS-15, and GDS-4. The cut point for MHI-1 was set retrospectively. The clinical interview assessed mood and depression by using the DCR-10 (diagnostic standard).
M a i n o u t c o m e m e a s u r e s Sensitivity, specificity, and area under the receiver-operating characteristic (ROC) curve.
M a i n r e s u l t s
17 of the 87 patients (20%) were diagnosed with depression by using the DCR-10. Sensitivity, specificity, positive and negative likelihood ratios, and ROC curve results for all tests are in the Table. The 4 tests did not differ for screening of depression.
C o n c l u s i o n
Short scales (Geriatric Depression Scale-4 and Mental Health Inventory-1) were comparable in sensitivity and specificity to long scales (Geriatric Depression Scale-30 and Geriatric Depression Scale-15) in screening for depression in older patients. 
C o m m e n t a r y
Depression is common, serious, and treatable, but it is underrecognized, particularly in elderly persons (1). Societal and cultural biases often hinder the diagnosis. The study by Pomeroy and colleagues compares 4 different screening instruments of variable length and content. The authors found that all 4 screening instruments had similar accuracy for detecting depression, and the 1-item MHI-1 had the best combination of sensitivity and specificity. These results need further validation for 3 reasons: First, this study assessed a small inpatient sample. Second, fewer than half of the patients approached were included in the study. Third, a relatively low interrater reliability (κ = 0.40) existed for MHI-1. Furthermore, the cut point for the MHI was defined retrospectively, and the item itself was not done independently and was extracted from a longer scale.
Should the clinician wait for further validation before implementing this approach to screening for depression? The answer is a resounding "no!" The literature on screening for depression in general medical outpatients (2) suggests that all of the screening instruments are relatively comparable, with sensitivity and specificity ranging from 80% to 90%, similar to the findings in this study. In a typical setting, a positive test result might raise the probability of depression from 10% to 15% to 35% to 45%, and a negative test result might lower the probability of depression to < 5%. Ensuring that all patients are screened for depression regularly is more important than small changes in the precision of the screening instrument (3 DIAGNOSIS
